Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 10-2010 | 09-2010 | 07-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 48 | N/A | N/A | 1 |
| TOTAL | $N/A | $78 | $N/A | $N/A | $1 |
| Non-Current Assets | |||||
| PPE Net | N/A | 25 | N/A | N/A | 3 |
| TOTAL | $N/A | $25 | $N/A | $N/A | $3 |
| Total Assets | $N/A | $103 | $N/A | $N/A | $4 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 0 | 1,015 | 0 | 0 | 50 |
| Accrued Expenses | N/A | 12 | N/A | N/A | N/A |
| Other current liabilities | N/A | 429 | N/A | N/A | N/A |
| TOTAL | $N/A | $1,457 | $N/A | $N/A | $50 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 13 | N/A | 13 |
| Other Non-Current Liabilities | 0 | 180 | -13 | 0 | 0 |
| TOTAL | $N/A | $180 | $N/A | $N/A | $13 |
| Total Liabilities | $N/A | $1,638 | $N/A | $N/A | $63 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 73 | N/A | 73 |
| Common Shares | N/A | 4 | N/A | N/A | 11 |
| Retained earnings | N/A | -2,286 | N/A | N/A | -86 |
| Other shareholders' equity | 0 | 685 | 0 | 0 | 0 |
| TOTAL | $N/A | $-1,535 | $N/A | $N/A | $-59 |
| Total Liabilities And Equity | $0 | $103 | $0 | $0 | $4 |